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ABSTRACT
In eukaryotes, bulk histone expression occurs in the S phase of the cell cycle. This highly conserved system
is crucial for genomic stability and proper gene expression. In metazoans, Stem-loop binding protein
(SLBP), which binds to 30 ends of canonical histone mRNAs, is a key factor in histone biosynthesis. SLBP
is mainly expressed in S phase and this is a major mechanism to limit bulk histone production to the S
phase. At the end of S phase, SLBP is rapidly degraded by proteasome, depending on two
phosphorylations on Thr 60 and Thr 61. Previously, we showed that SLBP fragment (aa 51–108) fused to
GST, is sufficient to mimic the late S phase (S/G2) degradation of SLBP. Here, using this fusion protein as
bait, we performed pull-down experiments and found that DCAF11, which is a substrate receptor of CRL4
complexes, binds to the phosphorylated SLBP fragment. We further confirmed the interaction of full-
length SLBP with DCAF11 and Cul4A by co-immunoprecipitation experiments. We also showed that
DCAF11 cannot bind to the Thr61/Ala mutant SLBP, which is not degraded at the end of S phase. Using
ectopic expression and siRNA experiments, we demonstrated that SLBP expression is inversely correlated
with DCAF11 levels, consistent with the model that DCAF11 mediates SLBP degradation. Finally, we found
that ectopic expression of the S/G2 stable mutant SLBP (Thr61/Ala) is significantly more toxic to the cells,
in comparison to wild type SLBP. Overall, we concluded that CRL4-DCAF11 mediates the degradation of
SLBP at the end of S phase and this degradation is essential for the viability of cells.
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Introduction
Eukaryotic S phase is characterized by chromosome replication,
which requires synthesis of DNA and sufficient amount of his-
tone proteins. Cells need to achieve very delicate balance between
DNA synthesis and histone levels, and confine the bulk histone
production to the S phase where the DNA amount is doubled.
Imbalance between DNA and histone synthesis may cause
improper gene expression, genomic instability and cell death.1-3
In metazoans, canonical histones are encoded by so-called
replication dependent histone genes. These multi-copy genes
lack introns and their mRNAs end in a conserved stem-loop
structure instead of a polyA tail. Other than the 50 capping, the
only processing reaction required to produce mature histone
mRNAs is an endolytic cleavage after the conserved stem-loop
structure at their 30 end.4 Histone mRNA expression is limited
to the S phase and this is regulated by transcriptional and post-
transcriptional mechanisms. At the G1-S transition, the tran-
scription of histone genes increases along with a significant
increase in the pre-mRNA processing efficiency, due to the
increase in SLBP.5-8 Together these account for the rapid
increase in the level of histone mRNAs as cells enter the S
phase. At the end of S phase, both the histone pre-mRNA proc-
essing and half-life of histone mRNAs are diminished in order
to rapidly shut down histone mRNA expression.4,7
Stem-loop binding protein (SLBP) binds to the conserved
stem-loop structure at the 30 ends of histone mRNAs and medi-
ates all aspects of histone mRNA metabolism including pre-
mRNA processing, nuclear export, translation and stability.9,10
SLBP is present at high levels only in S phase, and this is a
major mechanism to limit canonical histone production to the
S phase.4,8 SLBP expression is cell cycle regulated without a sig-
nificant change in its mRNA level.11 In G1, SLBP is kept low by
coordinate action of translation control and proteasome medi-
ated degradation.12 At late G1, SLBP expression significantly
increases and reaches to the highest level in S phase. At the end
of S phase (S/G2), SLBP is rapidly degraded by the proteasome
to shut down histone production.8,11 Degradation of SLBP
at the end of S phase requires specific phosphorylations of two
threonines in N-terminal TTP (aa 60–62) motif.8 The initial
trigger for the late S phase degradation of SLBP is Thr 61 phos-
phorylation by cyclin A/Cdk1,13 which emerges to be impor-
tant regulator of S-G2 transition.14-17 The phosphorylation of
Thr 61 depends on a downstream cyclin binding motif which is
critical for the proper recruitment of cyclin A/Cdk1 to SLBP.
Once Thr 61 is phosphorylated, it primes the subsequent phos-
phorylation of Thr 60 by CK2 and the doubly phosphorylated
SLBP is recognized by an unknown E3 ligase for the protea-
some mediated degradation.13,18
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The ubiquitin-proteasome system is the major pathway by
which cells target proteins for specific and time-controlled deg-
radation. Ubiquitin, a small protein highly conserved from
yeast to mammals, is covalently conjugated to proteins via a
cascade of 3 enzymatic activities. Ubiquitin is initially bound
and activated by an E1 ubiquitin activating enzyme in an ATP-
dependent manner and subsequently, it is transferred to an E2
ubiquitin conjugating enzyme. Finally, an E3 ligase recognizes
a specific substrate protein and bridge the substrate and E2 to
promote ubiquitin ligation. Once a polyubiquitin chain is
formed on the target protein, it is recognized by 26S protea-
some for degradation. Cullin-RING-based E3s (CRLs) consti-
tute a major subclass of E3 ligase complexes. In humans, 7
different Cullins (Cul 1, 2, 3, 4A, 4B, 5, 7) have been identified,
and each functions as a “scaffold” to assemble a CRL com-
plex.19 Mammalian cells express two closely related Cul4
paralogues Cul4A and Cul4B. Cul4s bind to DDB1 protein
through their N-termini. DDB1 functions as an adaptor protein
to recruit a DCAF (DDB1-Cul4 associated factors) protein,
which functions as the substrate receptor of the complex to spe-
cifically recognize and bind to the target proteins.20,21 Cul4-
based E3 ligases (CRL4) are implicated in the regulation of
chromatin biology including DNA damage response, histone
modification, and nucleosome assembly.22-24 Depletion of
Cul4A results in chromatin dysfunctions in yeast and mamma-
lian cells, and notably over expression of Cul4A has been
reported in many cancer types.25 There are several studies
reporting the critical roles of CRL4s in the cell cycle, especially
in S phase related degradations. CRL4s have been shown to tar-
get several key players including Cdt1, p21, p27, E2f1, Set8 and
Chk1 for degradation, in order to maintain proper S phase and
S-G2 progression 23,25-27.
Previously, we showed that SLBP fragment (between amino
acids 51–108) with just Thr 60 and Thr 61 as possible phos-
phoacceptor sites is sufficient to mediate the degradation of
SLBP at the end of S phase. When this SLBP fragment was
fused to GST, just like endogenous full-length SLBP, it was
degraded at the end of S phase depending on Thr 60 and Thr61
phosphorylations.13 Here, we used this phosphorylated fusion
protein as a bait, to pull-down the unknown E3 ligase that
mediates the S/G2 degradation of SLBP. Based on our results,
we proposed that Cul4A-DCAF11 E3 ligase mediates the degra-
dation of SLBP at the end of S phase, to inhibit histone
synthesis.
Results
GST-SLBP fragment fusion protein is sufficient to mimic the
S/G2 degradation of SLBP depending on two phosphorylations
on Thr 60 and Thr 61.13 Here, we produced the phosphorylated
form of this fusion protein, in order to pull-down the unknown
E3 ligase that mediates the S/G2 degradation of SLBP. We bac-
terially expressed and purified the GST-SLBP fragment fusion
protein, and as in our previous study, we in vitro phosphory-
lated Thr 61 and Thr 60 by cyclin/Cdk1 and CK2, respectively.
We also prepared Thr 61 and Thr 60 changed to alanine
mutant version, which is known to be stable at the end of
S phase.13 Using these fusion proteins, and GST, as baits, we
performed pull-downs from the lysate of HeLa cells
synchronized by double-thymidine method and collected at the
end of S phase. We ran the results on SDS-PAGE, and silver
stained (Fig. 1, Fig. S1). We concentrated on the bands that
came down with phosphorylated GST-SLBP fragment, but not
with S/G2 stable mutant or GST alone, and looked for a protein
with potential E3 ligase role. We tested several different buffers,
wash and staining conditions. With the pull-down conditions
explained in the materials and methods, and increased gel
staining, we repeatedly detected a faint band (»65 kDa), pres-
ent only in the pull-downs by phosphorylated SLBP fragment,
but not in the others (Fig. S1C). We sent the band to mass spec-
trometry analysis (LC-MS/MS), and repeatedly got DCAF11
with high mascot score (Fig. 1C). DCAF11 protein was shown
to bind CRL4 complex and was proposed as a substrate recog-
nizing subunit of the complex.20,21 Based on these results, we
decided to pursue DCAF11 as a candidate protein that mediates
SLBP degradation at the end of S phase.
Next, we validated our results with pull-downs followed by
western blot analysis. We ectopically expressed HA-tagged
DCAF11 and by western blot we detected HA-DCAF11 expres-
sion at expected size. Using lysates from those cells, we per-
formed pull-downs followed by western blot analysis. In line
with our mass spectrometry data we repeatedly showed that
HA-DCAF11 came down with phosphorylated GST-SLBP
fragment (Fig. 2A). We detected none or very little amount of
HA-DCAF11 in the pull-downs with either unphosphorylated
or S/G2 stable mutant (Thrs to Ala) versions of the bait
(Fig. 2A). Our results confirm that DCAF11 interacts with
SLBP fragment depending on the phosphorylations that are
required for the degradation of SLBP at the end of S phase.
In the CRL4 complex, DCAF11 was proposed to be the sub-
strate receptor that recruits the target proteins to Cul4. We also
checked whether our bait could pull-down Cul4A. We tran-
siently expressed Myc-Cul4A and repeated similar pull-down
experiments with our baits. With western blot analysis, we
detected significant amount of Myc-Cul4A that came down
with phosphorylated GST-SLBP fragment but not with unphos-
phorylated, S/G2 stable mutant version (Fig. 2B). Our results
show that SLBP fragment interacts with both DCAF11 and
Cul4A depending on phosphorylations, which are known to be
required for SLBP degradation at the end of S phase.
Ectopic expression of HA-DCAF11 induces proteasome
mediated degradation of SLBP
Next, we checked the levels of SLBP in response to ectopic
expression of HA-DCAF11 and detected a significant decrease
in the SLBP expression (Fig. 3A). Further, when we treated the
cells with proteasome inhibitor (MG132) in the last 2 hours
before the collection, SLBP levels were increased, suggesting
that ectopic expression of DCAF11 induces proteasome medi-
ated degradation of SLBP (Fig. 3D).
We also determined the effect of DCAF11 ectopic expres-
sion on DNA replication and the cell cycle. 46 hours after the
transfection of either empty vector or HA-DCAF11 construct,
we labeled the cells with BrdU for 2 hours and determined the
total BrdU incorporation levels using colorimetric BrdU detec-
tion kit. In each culture, we also quantified the viable cell
amount using Wst-1 assay and normalized the BrdU
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incorporation levels to the viable cell numbers, in order to
exclude the possible interfering effects of cell number differen-
ces. We detected a significant increase in the BrdU incorpo-
ration in the HA-DCAF11 transfected cells (Fig. 3B). In order
to determine the cell cycle distribution, we also performed pro-
pidium iodide staining followed by flow cytometry analysis. In
response to ectopic expression of HA-DCAF11, we detected a
significant accumulation of cells in the early S phase (Fig. 3C).
When considered together, our results suggest that HA-
DCAF11 expressed cells entered S phase and initiated DNA
replication, however, most of them accumulated in the early S
phase due to a significant delay in early S phase progression
(Fig. 3B, C), as is the case in previous SLBP knockdown
studies.28
SLBP interacts with both DCAF11 and Cul4A
Next, we determined whether DCAF11 interacts with full-
length SLBP with co-immunoprecipitation experiments. We
ectopically expressed HA-DCAF11 along with hisSLBP. In
order to prevent the DCAF11 induced decrease in SLBP expres-
sion, we treated the cells with proteasome inhibitor in the last
2 hours before the collection. We performed immunoprecipita-
tion with SLBP antibody and found that HA-DCAF11 is pulled
down along with SLBP (Fig. 4A). We also performed the
reverse co-immunoprecipitation experiment, where we immu-
noprecipitated HA-DCAF11 with HA antibody and detected
both his-tagged and endogenous SLBP in the immunoprecipi-
tate, confirming the SLBP and DCAF11 interaction (Fig. 4B).
We also determined whether Cul4A and SLBP can be
detected in the same complex. HeLa cells were co-transfected
with Myc-tagged Cul4A, HA-DCAF11 and hisSLBP and
immunoprecipitation was performed with SLBP antibody.
When we immunoprecipitated SLBP, we detected Myc-Cul4A
in the immunoprecipitate (Fig. 5A), showing that SLBP and
Cul4A were in the same complex. In the immunoprecipitates
with anti-SLBP, we detected a slower migrating band, which is
probably the neddylated version of Cul4A present in active
CRL4 complexes. We also did the reverse co-immunoprecipita-
tion experiment, where we immunoprecipitated Myc-Cul4A
and found both his-tagged and endogenous SLBP in the immu-
noprecipitate (Fig. 5B). Our results showed that SLBP and
Cul4A are present in the same complex, consistent with the
potential role of CRL4 in the regulation of SLBP expression
(Fig. 5).
DCAF11 interacts with wild type, but not Thr 61/Ala
mutant SLBP
Phosphorylation of Thr 61 by cyclin A/Cdk1 is known to
prime the subsequent phosphorylation of Thr 60 by CK2 and
doubly phosphorylated SLBP is recognized by an unknown E3
ligase for the degradation at the end of S phase.13,18 Mutation
of Thr 61 into Ala prevents this degradation.8 The DCAF11
Figure 1. Experimental setup for pull-downs. (A) Amino acid sequence of SLBP fragment, sufficient to mediate S/G2 degration of SLBP. All the possible phosphoacceptor
sites other than Thr 60 and Thr 61 were changed into alanine and were shown in light color. Mutations for the S/G2 stable version were shown below. (B) Schematic illus-
tration of baits and experimental setup. (C) Amino acid sequence of DCAF11 with the peptides recovered in LC-MS/MS.
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was found in the pull-downs by the SLBP fragment doubly
phosphorylated on Thr 60 and Thr 61. Based on these, we
checked whether Thr 61 is required for full-length SLBP and
DCAF11 interaction. We co-expressed either wild type or S/G2
stable mutant (Thr 61 to Ala) hisSLBP together with HA-
DCAF11 and immunoprecipitated with HA antibody. In line
with the GST pull-down assays, we showed that endogenous
and ectopically expressed wild type SLBP, but not the Thr 61/
Ala mutant version, came down with HA-DCAF11 (Fig. 4B),
suggesting that DCAF11 recognizes SLBP depending on Thr 61
phosphorylation, which is known to trigger S/G2 degradation
of SLBP.
RNAi based knockdown of DCAF11 leads to an increase in
SLBP levels and impairs Cul4A binding
In order to further examine the role of DCAF11 in regulation of
SLBP expression, we knocked down DCAF11 in HeLa cells
using DCAF11-specific siRNA and checked the SLBP level with
western blot analysis. In our knockdown experiments, we
obtained a decrease in DCAF11 levels by roughly 60%. How-
ever, we reproducibly saw a significant increase in SLBP levels
(Fig. 6A). In the DCAF11 siRNA transfected cells, we also
observed a decrease in BrdU incorporation (Fig. 6B). When we
performed propidium iodide staining followed by flow cytome-
try analysis, we detected a small, but significant increase in G1
and a decrease in S phase cells. Our results imply that, besides
its role in SLBP degradation, DCAF11 is critical for S phase
entry and DNA replication (Fig. 6C).
We also checked whether knockdown of DCAF11 impairs
Cul4A and SLBP interaction. We transfected cells with Myc-
Cul4A construct along with control or DCAF11-specific
siRNA. Next, we immunoprecipated the Myc-Cul4A and
checked whether SLBP came down with Myc-Cul4A. Although
we immunoprecipitated comparable amount of Myc-Cul4A,
we detected significantly less SLBP in the immunoprecipitates
from the DCAF11 siRNA transfected cells (Fig. 7). Our results
corroborate the model that DCAF11 binds and recruits SLBP
to Cul4A.
Thr61/Ala mutant SLBP induces cell death in HeLa cells
The TTP motif (containing Thr 60 and Thr 61), which regu-
lates the S/G2 degradation of SLBP, is highly conserved in
vertebrates, suggesting the importance of this regulation. In
order to determine whether S/G2 degradation of SLBP is criti-
cal for the cells, we transiently expressed wild type or S/G2
stable mutant hisSLBP (Thr 61 to Ala) in similar levels
(Fig. 8D), and compared their possible effects on the viable cell
number, the cell death and DNA replication (Fig. 8). We
assessed the viable cell number using Wst-1 cell viability assay,
and determined cell death levels using LDH cytotoxicity assay,
which quantifies the level of cell death by measuring the
released Lactate dehydrogenase (Fig. 8A, B). We repeatedly
found that S/G2 mutant version was significantly more toxic to
the cells, however, the actual dead cell amount induced in our
experiments appeared to be limited (Fig. 8A). In line with that,
we detected a modest decrease in the viable cell number in S/
G2 stable mutant SLBP expressed cells (Fig. 8B). We also deter-
mined the effects on DNA replication and cell cycle distribu-
tion. We found that ectopic expression of SLBP induces an
increase in the BrdU incorporation rate (Fig. 8C). When we
Figure 2. DCAF11 and Cul4A were pulled down by GST-SLBP fragment depending on phosphorylations on Thr 60 and Thr 61. HeLa cells were transfected with HA-
DCAF11 (A) or Myc-Cul4A (B) and collected 48 hrs after transfection. Cells were lysed and pull-downs were performed with the indicated baits as explained in the materi-
als and methods. GST-SLBPF (pTpTP) indicates phosphorylations on Thr 60 and Thr 61. Pull-downs were run on SDS-PAGE and immunoblotted for HA-DCAF11 or Myc-
Cul4A. The amounts of baits were assessed by Comassie Briliant Blue (CBB) staining.
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performed the propidium iodide staining followed by flow
cytometry analysis, we didn’t detect an obvious effect on the
cell cycle distribution of the cells (Fig. 8E). Overall, we observed
a limited difference between the cell cycle related effects of
wild-type and S/G2 stable mutant SLBP, however, our toxicity
results suggest that S/G2 degradation of SLBP is important for
the viability of cells.
Discussion
CRL4-DCAF11 mediates the late S phase degradation
of SLBP
SLBP is mainly expressed in S phase and this is a major mecha-
nism to limit histone production to the S phase.4,8 At the end
of S phase, SLBP undergoes proteasome mediated degradation
triggered by sequential phosphorylations of Thr 61 and Thr 60
by cyclin A/Cdk1 and CK2, respectively.13,18 Doubly phosphor-
ylated SLBP is recognized by an unknown E3 ligase for the late
S phase degradation. Previously, we showed that when fused to
GST, the N-terminal SLBP fragment (aa 51-108) with only
Thr 60 and 61 as potential phosphoacceptor sites, is sufficient
to mimic S/G2 degradation of SLBP in HeLa cells. Further, as
in full-length SLBP, when we mutated either of the threonines
to alanine, GST-SLBP fragment fusion protein became stable at
the end of S phase.13 Here, we used this GST fusion protein,
containing the SLBP fragment (aa 51-108) that is sufficient to
mediate S/G2 degradation, to pull-down unknown E3 ligase
responsible for the degradation of SLBP at the end of S phase.
We bacterially expressed and purified this GST-SLBP fragment
fusion protein and in vitro phosphorylated on Thr 60 and
Thr 61. We also produced the S/G2 stable mutant version,
where those threonines were converted to alanine in order to
prevent the phosphorylations required for S/G2 degradation.
Using these proteins as baits, we performed pull-down experi-
ments from late S phase HeLa cells’ lysates, followed by mass
spectrometry analysis (Fig. 1). According to our model Thr 60
and Thr 61 phosphorylations on SLBP are the regulators of the
SLBP degradation at the end of S phase. However, it was also
possible that there might be a cell cycle dependent regulation
on the unknown E3 ligase that we were searching for. There-
fore, in our initial pull-downs, we used lysates of the cells col-
lected at the end of S phase, where endogenous SLBP is
degraded and the E3 ligase should be active. In the pull-downs
by the phosphorylated GST-SLBP fragment, we repeatedly
found DCAF11 by mass spectrometry analysis. Next, we also
Figure 3. Ectopic expression of DCAF11 induces proteasome mediated degradation of SLBP. (A) HeLa cells were transfected with the empty vector (EV) or HA-DCAF11
construct and collected 48 hrs after transfection. Cells were lysed and whole cell extracts were immunblotted for HA-DCAF11, SLBP and Skp1 (as a loading control). SLBP
levels were quantified and the level in the EV cells was set to 1. In the right panel, results from 3 independent experiments were graphed as Mean § SD. (B) HeLa cells
were transfected with EV or HA-DCAF11 construct. 48 hours after transfection, BrdU was introduced into the cultures for 2 hours and BrdU incorporation levels were quan-
tified using colorimetric detection kit as explained in materials and methods. Mean BrdU incorporation values (n D 3) § SD were graphed as a percentage of the levels
detected in the EV transfected cells. (C) Cell cycle profiles of the cells were determined by PI (Propidium Iodide) staining followed by Flow Cytometry analysis. Right pan-
nel shows the mean § SD of 3 independent experiments. (D) Cells were transfected with EV or HA-DCAF11 and collected 48 after the transfection. In the lane 3, prote-
some inhibitor (MG132) was added for the last 2 hrs before collection. Cells were lysed and immunblotted for HA-DCAF11, SLBP and Skp1.
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validated our results by western blot analysis. We performed
pull-downs from HA-DCAF11 transfected cells and showed
that HA-DCAF11 was pulled down by phosphorylated GST-
SLBP fragment, but not with unphosphorylated or S/G2 stable
mutant versions (Fig. 2A). Previously, DCAF11 was shown to
bind CRL4 and was proposed as a substrate recognizing sub-
unit of CRL4 complex.20,21 In line with that, we showed that
Cul4A is also pulled down by GST-SLBP fragment again
depending on Thr 60 and Thr 61 phosphorylations (Fig. 2B).
Since we found DCAF11 and Cul4A in the pull-downs by the
phosphorylated SLBP fragment that mediates the S/G2 degra-
dation of SLBP, we decided to follow CRL4-DCAF11 as the
candidate E3 complex, responsible for the SLBP degradation at
the end of S phase.
Next, with co-immunoprecipitation experiments, we con-
firmed the interaction of DCAF11 and full-length SLBP in the
lysate (Fig. 4A). Parallel with our pull-down experiments, we
repeatedly showed that DCAF11 binds to wild type but not to
S/G2 stable mutant (Thr 61 to Ala converted) SLBP, confirming
that Thr 61 is required for DCAF11 and SLBP interaction
Figure 4. DCAF11 interacts with wild type, but not Thr 61/Ala mutant SLBP. (A) HeLa cells were transfected with HA-DCAF11 along with hisSLBP. Cells were treated
with MG132 for the last 4 hrs before collection. Cells were lysed and immunoprecipitations with nonspecific IgG or anti-SLBP were performed. Whole cell extract
(input) and immunoprecipitates were analyzed by western blot for indicated proteins. (B) HeLa cells were transfected with HA-DCAF11 along with wild type hisSLBP
(TTP) or Thr61/Ala mutant hisSLBP (TAP). Whole cell extracts (input) were subjected to immunoprecipitation (IP) with either nonspesific IgG or anti-HA and immuno-
precipitates were immunoblotted for indicated proteins.
Figure 5. SLBP interacts with Cul4A. HeLa cells were transfected with Myc-Cul4A, HA-DCAF11 and hisSLBP. Cells were treated with MG132 for the last 4 hours before col-
lection. Cells were lysed and immunoprecipitations with either nonspecific IgG, anti-SLBP (A) or anti-Myc (B) were performed. Whole cell extracts (input) and immunopre-
cipitates were analyzed with western blot for indicated proteins.
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Figure 6. Knockdown of DCAF11 induces SLBP expression. (A) HeLa cells were transfected with control (non-targeting) or DCAF11 specific siRNA, and collected 48 hrs after transfec-
tion. Cells were lysed and whole cell extracts were immunoblotted for DCAF11, SLBP, Cyclin A and Skp1. SLBP levels were quantified and the level in the control cells was set to 1.
Results from 3 independent experiments were graphed as mean§ SD in the panel on the right. (B) BrdU incorporation levels were quantified as explained in thematerials andmeth-
ods using colorimetric detection kit. Mean values (nD 3)§ SD were graphed as a percentage of the control siRNA transfected cells (C) Cell cycle profiles of the cells were determined
by PI staining followed by Flow Cytometry analysis. In the right panel, results from 3 independent experiments were graphed as mean§ SD.
Figure 7. Cul4A and SLBP interaction is impaired by DCAF11 RNAi. HeLa cells were transfected with Myc-Cul4A along with control (non-targeting) or DCAF11 spesific
siRNAs. Cells were lysed and immunoprecipitations with non-spesific IgG or anti-Myc were performed. Whole cell extracts (input) and immunoprecipitates were analyzed
by western blot for indicated proteins.
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(Fig. 4B). Since the phosphorylation of Thr 61 is required for
S/G2 degradation of SLBP, disruption of DCAF11 and SLBP
interaction by Thr 61 to Ala mutation fits with the model that
DCAF11 is the mediator of S/G2 degradation of SLBP.
We also determined whether we can detect Cul4A and SLBP
in the same complex. When we performed co-immunoprecipi-
tation experiments from proteasome inhibitor treated HeLa
cells, we detected Cul4A and SLBP in the same complex, con-
sistent with our model that DCAF11 recruits SLBP to CRL4 to
mediate its degradation (Fig. 5).
Cul4A itself is regulated, and in the active E3 ligase complex
the neddylated form (NEDD8 conjugated) is present.29 Consis-
tent with that, in the immunoprecipitate with the SLBP anti-
body, we detected a slower migrating Myc-Cul4A band, which
appeared as a faint band in the input (Fig. 5A). This enriched
band is probably the neddylated form of Cul4A, which is
required for the fully active Cul4A-based E3 ligase complex.
We also determined whether knockdown of DCAF11 will
impair the Cul4A and SLBP interaction. We showed that in the
DCAF11 siRNA transfected cells, co-immunoprecipitation of
SLBP with Cul4A were significantly inhibited (Fig. 7). Our
result further strengthens the model that DCAF11 recruits
SLBP to Cul4A-based complex.
In line with our model, we also demonstrated that SLBP
expression is inversely correlated with DCAF11 levels by
ectopic expression and siRNA experiments. We showed that
the ectopic expression of HA-DCAF11 triggered proteasome
mediated degradation of SLBP (Fig. 3A). Further, when we
knocked down DCAF11, again fitting with our model, we
detected a significant increase in the SLBP expression levels
(Fig. 6A).
We determined the effect of DCAF11 ectopic expression on
the BrdU incorporation, and detected an increase in the BrdU
incorporation levels (Fig. 3B). We also determined the cell cycle
distribution of those cells, and observed a significant accumula-
tion of the cells in early S phase suggesting an early S phase
delay (Fig. 3C). It appears that although the DNA replication
rate of individual cells was impaired causing an early S phase
delay and accumulation, since most of the cells in the culture
were in the S phase and started some level of DNA replication
(thus BrdU incorporation), we detected an increase in the
BrdU incorporation (Fig. 3B).
When we knocked down DCAF11, we detected a decrease in
the BrdU incorporation. We also detected an increase in the G1
cells (Fig. 6). It appears that in our knockdown experiments,
the remaining level of DCAF11 was sufficient to prevent a
stronger BrdU incorporation decrease and G1/S arrest. How-
ever, our results suggest that DCAF11 has critical functions in
S phase entry and DNA replication, which are presumably dis-
tinct than its role in SLBP degradation at the end of S phase.
Taken together, DCAF11 appears to be essential for S phase
entry and progression. However, after the ectopic expression of
DCAF11, we detected an early S phase delay similar to previ-
ously reported SLBP knockdown studies. It appears that while
Figure 8. S/G2 stable mutant SLBP induces cell death in HeLa cells. HeLa cells were transfected with EV, wild type hisSLBP (TTP) or S/G2 stable mutant (Thr 61/Ala)
hisSLBP (TAP). (A) 48 hrs after the transfection, cell death levels were assessed by LDH release assay, (B) cell viability was quantified using Wst-1 viability assay, and (C)
BrdU incorporation levels were quantified as explained in the materials and methods using colorimetric detection kit. Mean (n D 3) § SD were graphed as a percentage
of the values detected in the EV transfected cells. (D) Cell cycle profiles of the cells were determined by PI staining, followed by Flow Cytometry analysis. (E) Cells were
lysed and whole cell extracts were immunoblotted for SLBP and Skp1.
CELL CYCLE 1993
DCAF11 overexpression pushes the cells to the S phase, the sig-
nificant decrease in the SLBP level causes an early S- phase
delay, probably because of slowed rate of histone synthesis, just
like the effect seen in SLBP knockdown studies.28,30
SLBP is expressed in S phase. However, when we expressed
HA-DCAF11, despite the increase in S phase cells, SLBP levels
significantly decreased. Similarly, although DCAF11 siRNA
had inhibitory effect on S phase entry, SLBP levels went up sig-
nificantly in those cells. In both experiments the SLBP levels
don’t change in line with the changes in the percentage of
S phase cells. These findings suggest that the effects on SLBP
expression in overexpression and knockdown experiments
were not due to the indirect effects of the cell cycle profile
changes, but possibly due to the direct regulation of SLBP by
DCAF11.
S/G2 stable mutant SLBP is toxic to the cells
The motifs that control S/G2 degradation of SLBP (TTP and
downstream cyclin binding site) are conserved in vertebrates.
Moreover, when we expressed either XSLBP1 or mSLBP in
HeLa cells, both are also degraded at the end of S phase
(Koseoglu, MM and Marzluff, WF, unpublished data). The
possible conservation of S/G2 degradation mechanism sug-
gests that it is crucial for the cells. In order to determine the
possible effects of inhibiting the S/G2 degradation of SLBP,
we transiently expressed wild type and S/G2 mutant (Thr 61/
Ala) SLBP at similar protein levels and analyzed their effects
on BrdU incorporation, living cell numbers and cell death
(Fig. 8). Our BrdU incorporation results suggest that DNA
replication rate increases in response to ectopic expression of
SLBP, which is probably due to the previously identified role
of new histone supply on regulation of replication fork
speed.31 Proper regulation of histone synthesis is also critical
for the cell viability.1 When we determined the cell death level,
we reproducibly observed a significantly higher toxic effect of
S/G2 stable mutant SLBP, than the wild-type (Fig. 6A). We
also quantified the living cell numbers, which reflects both cell
division and cell death rate at the same time, and detected a
modest decrease in the viable cell number in response to S/G2
stable SLBP expression (Fig. 8B). It appears that the actual
amount of cell death, we detected in HeLa cells is limited.
However, the reproducible induction of significantly higher
cell death by S/G2 stable mutant SLBP, than the wild-type,
implies that SLBP degradation at the end of S phase is critical
for the cell viability. Overall, our result suggests that prevent-
ing the S/G2 degradation of SLBP induces cell death, and the
mechanisms and possible involvement of checkpoints are yet
to be investigated.
CRL4s as emerging power of S phase
In recent years, several studies revealed significant roles for
Cul4-based E3 ligase complexes in the cell cycle progression,
especially by mediating the S phase related degradations of sev-
eral key regulatory proteins. CRL4Cdt2, which emerged as criti-
cal regulator of cell cycle, was found to mediate S phase
degradations of several key players including Cdt1, p21, Set8,
Chk1.25 CRL4Cdt2 was also linked to proper expression of
histone genes by mediating the degradation of Set8. CRL4Cdt2
mediated S phase degradation of Set8 was shown to be required
for transcription of histone genes.32 DCAF11 was previously
shown to bind CRL4 and was proposed as a substrate recogniz-
ing subunit of the CRL4 complex.20 However, there was almost
no information about its targets. The only related study was in
C. elegans, where the ortholog of DCAF11 was proposed to be
involved in the regulation of the transcription factor SKN-1,
which protects animals from stress and promotes longevity.33
In our study, we concluded that CRL4DCAF11 mediates the deg-
radation of SLBP at the end of S phase, which is an important
mechanism to coordinate cell cycle and histone biogenesis, and
proposed a role for CRL4DCAF11 in the mammalian system.
Conclusion
SLBP is the major factor that regulates all aspects of histone
mRNA metabolism. Restriction of SLBP expression to the S
phase is a major mechanism to limit canonical histone produc-
tion to the S phase. SLBP is rapidly degraded at the end of S
phase as a mechanism to shut down canonical histone produc-
tion. Here, we proposed that CRL4DCAF11 mediates the degra-
dation of SLBP at the end of S phase and this degradation is
critical for the cell viability. Overall, our study revealed a signif-
icant role for CRL4DCAF11 in regulation of histone biosynthesis
and introduced a new component to the emerging S phase
related roles of CRL4s.
Materials and methods
GST-SLBP fragment fusion protein
The GST-SLBP fragment construct for bacterial expression was
prepared as explained in Koseoglu et al., 2008.13 Roughly, the
SLBP fragment (aa 51-108) was sub-cloned into the pGEX2T
vector just after the glutathione S-transferase (GST) tag using a
PCR-generated insert with Eco-RI and Bam-HI sites. All phos-
phoacceptor amino acids except Thr60 and Thr61 were
converted into alanine using Quickchange site directed muta-
genesis protocol using appropriate primers (Stratagene). For
bacterial expression, the constructs were transformed into
BL21 (DE3) cells. The expression of GST-SLBP fragment in
BL21 (DE3) cells was induced by 0,75 mM IPTG for 2 hours at
37C. Induced cells were lysed by sonicating on ice for 4 times.
Lysates were clarified by centrifugation for 10 min at
14,000 rpm at 4C. GSH beads were added to the lysate and
rocked at 4C for 2 hrs. Purified proteins were analyzed by
SDS-PAGE and silver staining. For pull-down experiments,
GST-SLBP bound to the beads was used.
Phosphorylation of the baits
Sequential phosphorylations of the threonines were performed
using bacolovirus-expressed recombinant cyclin/CDK1 and
CK2 (NEB) as in our previous publication.13 Roughly, 30 ml
reaction mixtures with 3 mg of substrate protein (bait), 5 mM
ATP, the kinase and either commercial (provided with kinases)
or homemade kinase buffer (50 mM b-glycerophosphate,
20 mMNaF, 1.5 mM EGTA, 0.05 % NP-40 with 1 mM DTT,
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1 mM PMSF, 500 mMNa3VO4 and supplemented with 10 mM
MgCl2) were set and incubated at 30C for 2 hours. In order to
optimize the reactions, 8 mCi of radiolabeled [g-32P] ATP was
used and samples were run on SDS-PAGE, coomassie stained
and analyzed with phosphoimager.
Cell culture and synchronization
HeLa cells were grown in Dulbecco modified Eagle’s medium
with 10% fetal bovine serum and penicillin-streptomycin. Cells
were synchronized by double-thymidine method according to
previously explained protocol.13 Roughly, cells were blocked
for 19 hrs with 2 mM thymidine and released into fresh
medium for 9 hrs after washing with phosphate-buffered saline
(PBS). Then, cells were blocked again with 2 mM thymidine for
16 hrs to arrest all the cells at the beginning of S phase. Finally,
cells were washed with PBS and released into fresh medium.
Synchronous progression of the cells through S, G2 and M
phases were followed by flow cytometry analysis. Every two
hours after the release, cells were collected and the cell cycle
profiles were determined by propidium iodide staining followed
by flow cytometry analysis (Fig. S1).
GST pull-downs
Cells were lysed in NP-40 Lysis Buffer (150 mM NaCl, 50 mM
Tris-HCl (pH 8), 1 mM dithiothreitol, 1 mM phenylmethylsul-
fonyl fluoride, 1x protease inhibitor mixture (Roche) and 0.5%
NP-40). 10 mg of whole cell extract were precleared with GSH
beads by rocking for 2 hours at 4C. 25 mg of phosphorylated
GST-SLBPfragment, S/G2 stable mutant version or GST on
beads were added into lysate and incubated at 4C with end-
over-end mixing for 2 hours. Baits were precipitated with GSH
beads and washed 3 times with NP-40 Lysis Buffer for 30
minutes at 4C. Proteins were eluted from GSH beads by add-
ing 2X SDS Laemli Buffer and resolved on SDS-PAGE. The
protein bands were stained using commercial Silver Stain for
Mass Spectrometry kit (Pierce) according to manufacturer’s
protocol. Determined bands were cut and stored with 10 ml of
methanol in order to prevent drying. LC-MS/MS analyses were
performed in Institute of Biochemistry and Biophysics (War-
saw, Poland).
Transfection and RNAi interference
HeLa cells were seeded at 90% confluency on 6well plate and
transfected with 2 mg DNA and Lipofectamine2000 (Invitro-
gen) according to manufacturer’s protocol. Gene silencing was
performed by transfecting HeLa cells with 50 nM siRNA ( GE
Dharmacon) with DharmaFECT 1 (Dharmacon) according to
the manufacturer’s protocol. Cells were transfected with either
ON-TARGETplus siGENOME Human DCAF11 siRNA or
control ON-TARGETplus Non-Targeting pool (Dharmacon).
Immunoprecipitation
Cells were lysed in NP-40 Lysis Buffer. Around 1 mg of whole
cell extract was incubated with 4 mg of indicated antibodies for
3–4 hrs at 4C with shaking. Nonspecific IgG was used as a
negative control. Immune complex was recovered on protein A
sepharose beads by overnight rocking at 4C. Precipitates were
washed 3 times with the lysis buffer for 30 minutes and eluted
by boiling in 2X SDS Laemli Buffer. Eluted proteins were
resolved by SDS-polyacrylamide gel electrophoresis (PAGE),
semi-dry transferred to a PVDF membrane and immunoblot-
ted with indicated antibodies.
Analysis of cell death
Cell death in each culture was quantified using commercial col-
orimetric LDH toxicity kit (Roche) according to manufacturer’s
protocol. Absorbance density (OD) values at 480nm were mea-
sured using a plate reader.
Detection and quantification of BrdU incorporation
BrdU incorporation was detected using Colorimetric BrdU
Detection Kit (Roche). In each culture, viable cell amount was
also quantified using Wst-1 assay kit (Roche) and total BrdU
incorporation levels were normalized to the viable cell num-
bers. In a combined protocol, cells were incubated in the pres-
ence of BrdU for 2 hours. Next, in order to quantify the viable
cells, Wst- 1 reagent was added for 2 hours and OD values
were measured at 420 nm with plate reader. After that, cells
were carefully washed with PBS. Next, using Colorimetric
BrdU Detection Kit (Roche), cells were fixed and stained with
BrdU antibody according to manufacturer’s protocol. BrdU
incorporation values were quantified by OD measurements at
370 nm (reference wavelength: 492nm).
Drugs and antibodies
Cyclin A, SLBP (H-3) and Myc antibodies were purchased from
Santa Cruz. DCAF11 (Sigma), HA (Covance), Skp1 (BD) anti-
bodies were purchased from indicated companies. MG132 and
Thymidine were purchased from Sigma.
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